Millions of heart failure patients could be cured with tiny patches of cells that can be stitched directly on to their damaged organ.
British scientists have developed a way of growing tiny amounts of heart tissue in the laboratory, which can be observed ‘beating away’ on their own in Petri dishes.
Researchers at Cambridge University hope that this breakthrough will lead to a cure for the debilitating condition of heart failure. This disease affects more than 1million in the UK, and millions around the world.
The thumb-sized patches are made using stem cells, which can be grown into any type of human cell, and are constructed into tissue using tiny ‘scaffolding’ made of the protein collagen.

British scientists have developed a way of growing tiny amounts of heart tissue in the laboratory, which can be observed ‘beating away’ on their own in Petri dishes
The heart patches were tested on rats. They will be soon made available for human trials. This could, if it is successful, lead to mass production of millions upon heart-healthy heart patches.
Professor Sanjay Sinha, who is leading the pioneering research, said: ‘When someone has a heart attack, their heart muscle is starved of vital nutrients and oxygen.
‘We can lose a billion heart cells in one heart attack and the human heart doesn’t regenerate itself. The scarring process heals the muscle. You can never get the muscle back.
‘This means the heart just doesn’t pump efficiently and patients are breathless and struggle with things they used to take for granted like walking upstairs or getting dressed.
‘Of people who develop heart failure, half will be dead within five years. This is the same as various forms of cancer.
‘At the moment all we can do is give them tablets, but that doesn’t cure the underlying problem, which is the lost heart muscle.
‘The only real treatment is a heart transplant and this country only does 200 a year. We have come up with a new solution – using the power of stem cells to mend damaged hearts – which could restore their heart function and their lives back to normal. There are hundreds of thousands of people who could benefit.’
Professor Sinha said the research was ‘tremendously exciting’ and that if human trials, which will monitor patients over several years, are successful the patches could be used routinely on the NHS within 15 years.
He said: ‘Every time I go into the lab with my team growing little heart patches and look at them beating away it never ceases to amaze me.
‘We’ve created this floating batch of beating hearts. These heart cells and little patches are like babies, they need to be fed every day with nutrients.’
The team’s early experiments were very successful. They found that the cells grown in the laboratory can be injected into the hearts of rats suffering from heart problems. Professor Sinha added: ‘The next challenge is scaling it up. While we could use one million cells to make the patch for rats, the human patch might require either 100million, 500million, or both.
‘The goal is to be able to have patches we can stitch directly on to damaged hearts when patients come in for surgery. We want a production line where you can make tens of thousands of patches, then a surgeon just picks it off the shelf and gives it to a patient.’
Professor Sinha’s work is funded by the British Heart Foundation, which is aiming to raise another £3million for research into regenerative medicine through being Charity of the Year for the 2022 TCS London Marathon. Professor Sinha runs the marathon in order to fund his own research.
Professor James Leiper, associate medical director at the British Heart Foundation, said: ‘Growing patches of real heart tissue from stem cells may sound like science fiction, but it is at the cutting edge of the life-changing research that the Foundation funds. Nearly one million British citizens are affected by heart failure. Unfortunately, there’s no cure.
‘Heart failure is a debilitating condition, making everyday tasks incredibly difficult and causing a huge decrease in quality of life.
‘These heart patches could be a giant leap forward for regenerative medicine and the answer to finding a desperately needed treatment for heart failure – offering hope to the millions of people affected.’